NIH director nominee is Francis Collins
This article was originally published in The Gray Sheet
Physician-geneticist Francis S. Collins, President Obama's choice to direct the National Institutes of Health, is an expert on and ambitious proponent of personalized medicine, as showcased by his latest book, The Language of Life: DNA and the Revolution in Personalized Medicine (due to be published in 2010). Collins directed NIH's National Human Genome Research Institute from 1993-2008, which resulted in the mapping of the human genome and helped usher in the era of personalized medicine. In that role, Collins "consistently met projected milestones ahead of schedule and under budget," the White House notes in a July 8 statement. AdvaMed applauded the nomination, noting the central role of molecular diagnostic research in personalized medicine
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.